Home warm baths to reduce seizures in CDKL5 disorder
Part of Brain & nervous system clinical trials.
This trial tests whether daily warm baths at home can help reduce seizures in children with CDKL5 deficiency disorder—a rare genetic condition that causes hard-to-control epilepsy. The study wants to see if heat therapy is safe and actually works for these children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be diagnosed with CDKL5 deficiency disorder (confirmed by genetic testing) and have epileptic seizures
- Child must be between 6 months and 14 years old
- Seizures must continue despite trying at least 2 different anti-seizure medications
- Child must have had at least 8 motor seizures (sudden uncontrolled movements) every 4 weeks in the past 8 weeks
- Current seizure medications and diet must stay the same for at least 4 weeks before and during the trial
- Parent or caregiver must be able to keep a daily record of seizures on an electronic device and give written permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ganaxolone, a seizure medicine, to see if it can reduce seizures in young children with CDKL5 deficiency. Participants get the real medicine or a placebo, and families help track seizures every day.
This study is for anyone diagnosed with CDKL5 disorder who can be seen at participating clinics or is already listed in an international CDKL5 registry. The goal is to help researchers better understand the condition and support future research.
This study tests whether changing the gut environment can help reduce seizures in children and adults with CDKL5 deficiency disorder, a rare genetic condition that causes hard-to-control seizures. It is designed for people whose seizures aren't controlled by medicine and who do not have other gut issues or special diets.
This study tests a new medicine (S230815) given by lumbar puncture (spinal tap) to see if it helps reduce seizures in children with a specific genetic cause of epilepsy. It is for children aged 2 to 12 who have not responded well to other treatments.
This trial studies how well a ketogenic diet works for children with hard-to-treat epilepsy or certain other diseases. It aims to see if the diet improves quality of life.
This trial tests whether starting a special high-fat diet (ketogenic diet) early can prevent epileptic spasms in babies with genetic epilepsy. It uses a specific formula called KetoVie and is for infants under 9 months old.
Hear when a new CDKL5 Deficiency Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.